Murine model of ferric chloride‐induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2006-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1538-7836.2006.01703.xPMID 16420573
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Roles of protease-activated receptors in a mouse model of endotoxemia.

  2006cited by this paper
• Effects of factor IX or factor XI deficiency on ferric chloride‐induced carotid artery occlusion in mice

  2005cited by this paper
• The effects of ximelagatran and warfarin on the prophylaxis of a caval vein thrombosis and bleeding in the anaesthetized rat

  2005cited by this paper
• Murine thrombosis models

  2004cited by this paper
• Enhancement of Fibrinolysis by EF6265 [(S)-7-Amino-2-[[[(R)-2-methyl-1-(3-phenylpropanoylamino)propyl]hydroxyphosphinoyl] methyl]heptanoic Acid], a Specific Inhibitor of Plasma Carboxypeptidase B

  2004cited by this paper
• Thrombin-activatable fibrinolysis inhibitor.

  2004cited by this paper
• 96-Well Plate Colorimetric Assay for Ki Determination of (+/-)-2-Benzylsuccinic Acid, an Inhibitor of Carboxypeptidase A: A Laboratory Experiment in Drug Discovery

  2004cited by this paper
• Synthesis and evaluation of imidazole acetic acid inhibitors of activated thrombin-activatable fibrinolysis inhibitor as novel antithrombotics.

  2003cited by this paper
• Thrombin-Activable Fibrinolysis Inhibitor Levels in the Acute Phase of Ischemic Stroke

  2003cited by this paper
• Inhibition of Factor Xa Reduces Ischemic Brain Damage After Thromboembolic Stroke in Rats

  2003cited by this paper
• Carboxypeptidase B inhibitors reduce tissue factor-induced renal microthrombi in rats.

  2003cited by this paper
• Reversible inhibitors of TAFIa can both promote and inhibit fibrinolysis

  2003cited by this paper
• Stabilization Versus Inhibition of TAFIa by Competitive Inhibitors in Vitro *

  2003cited by this paper
• Thrombin‐activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)

  2003cited by this paper
• Thrombin‐activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system

  2003cited by this paper
• Protection against thrombosis in mice lacking PAR3.

  2002cited by this paper
• In vivo regulation of plasminogen function by plasma carboxypeptidase B.

  2002cited by this paper
• Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life.

  2002cited by this paper
• Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels in Patients with Coronary Artery Disease Investigated by Angiography

  2002cited by this paper
• Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis

  2001cited by this paper
• Variable protection of beta 3-integrin--deficient mice from thrombosis initiated by different mechanisms.

  2001cited by this paper
• Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis.

  2000cited by this paper
• Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat.

  1999cited by this paper
• A Novel Approach to Arterial Thrombolysis

  1999cited by this paper
• A novel approach to arterial thrombolysis.

  1999cited by this paper
• Plasma TAFI Levels Influence the Clot Lysis Time in Healthy Individuals in the Presence of an Intact Intrinsic Pathway of Coagulation

  1998cited by this paper
• A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis.

  1998cited by this paper
• Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.

  1998cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

  1996cited by this paper
• The effectiveness of implementing the weight-based heparin nomogram as a practice guideline.

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

  1996cited by this paper
• Plasma carboxypeptidases as regulators of the plasminogen system.

  1995cited by this paper
• Importance of platelets in experimental venous thrombosis in the rat.

  1992cited by this paper
• Rat model of arterial thrombosis induced by ferric chloride.

  1990cited by this paper
• A new experimental model of venous thrombosis in rats involving partial stasis and slight endothelium alterations.

  1987cited by this paper
• Streptomyces R61 DD-carboxypeptidase: hydrolysis of X-D-alanyl-D-alanine peptides measured by a fluorometric assay.

  1984cited by this paper
• Purification and properties of a carboxypeptidase inhibitor from potatoes.

  1974cited by this paper

• Controllable Thrombolysis Using a Nanobubble-Imaging-Guided rtPA Targeted Delivery Strategy

  2024cites this paper
• Mediation of long-pulsed ultrasound enhanced microbubble recombinant tissue plasminogen activator thrombolysis in a rat model of platelet-rich thrombus

  2024cites this paper
• Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach.

  2024cites this paper
• Ferumoxytol-enhanced MRI assessment of venous Thrombus resolution and macrophage content in a murine deep vein thrombosis model.

  2024cites this paper
• Intravital Imaging of Thrombosis Models in Mice

  2023cites this paper
• Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease

  2022cites this paper
• Pre-administration of a carboxypeptidase inhibitor enhances tPA-induced thrombolysis in mouse microthrombi: Evidence from intravital imaging analysis.

  2022cites this paper
• Plant sources of bioactive peptides

  2021cites this paper
• Preparation of injectable clopidogrel loaded submicron emulsion for enhancing physicochemical stability and anti-thrombotic efficacy.

  2021cites this paper
• KAJIAN ETNOBOTANI, FITOKIMIA, FARMAKOLOGI DAN TOKSIKOLOGI SUKUN (Artocarpus altilis (Park.) Fosberg)

  2021cites this paper
• High fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice.

  2020cites this paper
• Imaging of Clot by 99mTc-HMPAO Labeled Platelet in Animal Model Induced Thrombosis

  2020cites this paper
• Aqueous extract of Whitmania pigra Whitman ameliorates ferric chloride-induced venous thrombosis in rats via antioxidation

  2020cites this paper
• Extracellular DNA—A Danger Signal Triggering Immunothrombosis

  2020cites this paper
• Selective inhibition of carboxypeptidase U may reduce microvascular thrombosis in rat experimental stroke

  2020cites this paper
• Thrombin-responsive engineered nanoexcavator with full-thickness infiltration capability for pharmaceutical-free deep venous thrombosis theranostics.

  2020cites this paper
• By word of mouse: using animal models in venous thrombosis research

  2020cites this paper
• Choosing a mouse model of venous thrombosis: a consensus assessment of utility and application

  2019influential citation
• Evaluation of commonly used tests to measure the effect of single-dose aspirin on mouse hemostasis.

  2019cites this paper
• Antithrombotic Effect of Oral Administration of Mozuku (Cladosiphon okamuranus, Brown Seaweed) Extract in Rat.

  2019cites this paper
• The influence of coagulation factor XIII-A V34L mutation onclot formation and stability

  2019cites this paper
• Antithrombotic efficacy of direct oral anticoagulants on patency rate following microsurgical anastomosis in crushed rat arteries.

  2019cites this paper
• Choosing a Mouse Model of Venous Thrombosis.

  2019cites this paper
• Fibrinolysis and Inflammation in Venous Thrombus Resolution

  2019cites this paper
• THE ROLE OF ACTIVATED THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR (TAFIA) IN ATHEROSCLEROSIS PROGRESSION THE ROLE OF ACTIVATED THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR (TAFIA) IN ATHEROSCLEROSIS PROGRESSION By DHULFIHA MUZAFAR GANI, B.H.Sc. (Hons)

  2018cites this paper
• Biochemical characterization of the YBPCI miniprotein, the first carboxypeptidase inhibitor isolated from Yellow Bell Pepper (Capsicum annuum L). A novel contribution to the knowledge of miniproteins stability.

  2018cites this paper
• A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss

  2018cites this paper
• Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin‐activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models

  2018cites this paper
• Biochemical and MALDI-TOF Mass Spectrometric Characterization of a Novel Native and Recombinant Cystine Knot Miniprotein from Solanum tuberosum subsp. andigenum cv. Churqueña

  2018cites this paper
• Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease

  2017cites this paper
• Xanthohumol isolated from Humulus lupulus prevents thrombosis without increased bleeding risk by inhibiting platelet activation and mtDNA release

  2017cites this paper
• Studies on New Activities of Enantiomers of 2-(2-Hydroxypropanamido) Benzoic Acid: Antiplatelet Aggregation and Antithrombosis

  2017cites this paper
• Differential anti-thrombotic benefit and bleeding risk profiles of antagonists of protease-activated receptor 1 and 4 in Cynomolgus Macaques.

  2016cites this paper
• Intriguing Cystine-Knot Miniproteins in Drug Design and Therapeutics

  2016cites this paper
• Assessment of Venous Thrombosis in Animal Models

  2016cites this paper
• Animal Models of Thrombosis From Zebrafish to Nonhuman Primates: Use in the Elucidation of New Pathologic Pathways and the Development of Antithrombotic Drugs.

  2016cites this paper
• In Vivo or Ex Vivo Models of Thromobis

  2016cites this paper
• THE ROLE OF CYCLOOXYGENASE-1 (COX-1) AND CYCLOOXYGENASE-2 (COX-2) IN A VENOUS THROMBOSIS MOUSE MODEL

  2016cites this paper
• Murine Models of Thrombosis and Hemostasis

  2016cites this paper
• Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release

  2016cites this paper
• Venous thrombosis

  2015cites this paper
• Biochemical characterization of a novel carboxypeptidase inhibitor from a variety of Andean potatoes.

  2015cites this paper
• Inhibition of thrombin-activated fibrinolysis inhibitor decreases postoperative adhesion.

  2015cites this paper
• Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel.

  2015cites this paper
• In Vivo or Ex Vivo Models for Testing Thrombosis and Hemostasis

  2015cites this paper
• A novel peptide inhibitor of platelet aggregation from stiff silkworm, Bombyx batryticatus.

  2014cites this paper
• Pivotal role of mast cell carboxypeptidase A in mediating protection against small intestinal ischemia-reperfusion injury in rats after ischemic preconditioning.

  2014cites this paper
• Thrombin-activatable fibrinolysis inhibitor is activated in an instant blood-mediated inflammatory reaction after intraportal islet transplant.

  2014cites this paper
• A Rat Model of Thrombosis in Common Carotid Artery Induced by Implantable Wireless Light-Emitting Diode Device

  2014cites this paper
• Insights into thrombin activatable fibrinolysis inhibitor function and regulation

  2013cites this paper
• Thrombin Activatable Fibrinolysis Inhibitor: A Putative Target to Enhance Fibrinolysis

  2013cites this paper
• Darexaban: anticoagulant effects in mice and human plasma in vitro, antithrombotic effects in thrombosis and bleeding models in mice and effects of anti-inhibitor coagulant complex and recombinant factor VIIa.

  2013cites this paper
• Circulating Progenitor and Mature Endothelial Cells in Deep Vein Thrombosis

  2013cites this paper
• Anti-thrombotic Effects of Modified Jeho-tang using a FeCl₃-induced Carotid Arterial Thrombosis Model

  2013cites this paper
• Vascular Gas6 contributes to thrombogenesis and promotes tissue factor up-regulation after vessel injury in mice.

  2013cites this paper
• Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl3-induced occlusive thrombus formation in the inferior vena cava of mice

  2013cites this paper
• Screening of Preventive Effects of Herbal Prescriptions in Rat Model of Arterial Thrombosis Induced by Ferric Chloride

  2013cites this paper
• Contrast ultrasound for the quantification of deep vein thrombosis in living mice: effects of enoxaparin and P2Y12 receptor inhibition

  2013cites this paper
• Cross-modulatory effects of clopidogrel and heparin on platelet and fibrin incorporation in thrombosis

  2013cites this paper
• Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo

  2012cites this paper
• Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis.

  2012cites this paper
• In vivo monitoring of venous thrombosis in mice

  2012cites this paper
• Vascular Gas6 contributes to thrombogenesis and promotes tissue factor upregulation following vessel injury in mice

  2012cites this paper
• Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins

  2012cites this paper
• Thrombin-activatable fibrinolysis inhibitor and bacterial infections

  2011cites this paper
• An update on the role of carboxypeptidase U (TAFIa) in fibrinolysis.

  2011cites this paper
• Doxorubicin-induced platelet procoagulant activities: an important clue for chemotherapy-associated thrombosis.

  2011cites this paper
• Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa

  2011cites this paper
• Anti‐angiogenic effects of two cystine‐knot miniproteins from tomato fruit

  2011cites this paper
• Evaluation of anti-platelet and anti-thrombotic effects of cilostazol with PFA-100® and Multiplate® whole blood aggregometer in vitro, ex vivo and FeCl3-induced thrombosis models in vivo.

  2011cites this paper
• Black soybean extract can attenuate thrombosis through inhibition of collagen-induced platelet activation.

  2011cites this paper
• Optimization of Ferric Chloride Induced Carotid Artery Thrombosis Model in a Rat: Effect of Ginkgo biloba Extracts

  2011cites this paper
• Effects of modified Je-Ho-Tang on ferric chloride-induced thrombosis in a rat model and of peripheral circulatory disturbance in a mouse model

  2010cites this paper
• Biological action of two tomato cysteine-rich miniproteins

  2010cites this paper
• What has been learnt from the thrombin‐activatable fibrinolysis inhibitor‐deficient mouse?

  2010cites this paper
• Medicinal use of potato‐derived products: a systematic review

  2010cites this paper
• Platelet P2Y12 Receptor Influences the Vessel Wall Response to Arterial Injury and Thrombosis

  2009cites this paper
• Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)

  2009cites this paper
• Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

  2009cites this paper
• Identification of Coagulation Factor XI as a Ligand for Platelet Apolipoprotein E Receptor 2 (ApoER2)

  2009cites this paper
• Potato Proteins, Lipids, and Minerals

  2009cites this paper
• EF6265, a novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor, protects against sepsis-induced organ dysfunction in rats*

  2009cites this paper
• ACE2 Activation Promotes Antithrombotic Activity

  2009cites this paper
• Antithrombotic effect of clopidogrel in a vena cava thrombosis model in obese mice.

  2009cites this paper
• Lipopolysaccharide augments venous and arterial thrombosis in the mouse.

  2008cites this paper
• Antithrombotic Effects due to Pharmacological Modulation of Thrombin-Activatable Fibrinolysis Inhibitor in Rats

  2008cites this paper
• Engineered human soluble calcium-activated nucleotidase inhibits coagulation in vitro and thrombosis in vivo.

  2008cites this paper
• Overview of murine thrombosis models.

  2008cites this paper
• Pharmacological Assays in Thrombosis and Haemostasis

  2007cites this paper
• Murine models of vascular thrombosis (Eitzman series).

  2007cites this paper
• Murine Models of Vascular Thrombosis

  2007cites this paper
• Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis

  2007cites this paper
• Regulation of Hemostasis and Thrombosis Insights from Murine Models

  2007cites this paper
• A role for procarboxypepidase U (TAFI) in thrombosis.

  2007cites this paper
• Vascular functions of the plasminogen activation system.

  2007cites this paper
• Is exogenous tissue plasminogen activator necessary for antithrombotic efficacy of an inhibitor of thrombin activatable fibrinolysis inhibitor (TAFI) in rats?

  2007influential citation
• Characterization of rat thrombin‐activatable fibrinolysis inhibitor (TAFI) – a comparative study assessing the biological equivalence of rat, murine and human TAFI

  2006cites this paper
• Effects of factor XI deficiency on ferric chloride‐induced vena cava thrombosis in mice

  2006cites this paper
• Experimental models of thrombosis and atherosclerosis.

  2006cites this paper
• Endogenous t-PA release and pharmacological thrombolysis - Experimental animal studies of the coronary circulation

  2006cites this paper